通过工程三酶对神经毒剂VX解毒的机械洞察力
Lingjuan He1, Linquan Wang1, Yuzhuang Fu2
1Key Laboratory of Chemical and Biological Processing Technology for Farm Products of Zhejiang Province, Zhejiang Provincial Collaborative Innovation Center of Agricultural Biological Resources Biochemical Manufacturing, School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou, 310023, China.
Biochemical and biophysical research communications
|July 6, 2025
概括
工程三酶 (PTE) 变种显示V型神经毒剂的降解增强. 循环7中的结构变化提高了VX清除的催化效率和立体选择性.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 计算化学的计算化学
背景情况:
- 神经毒剂由于其极端的毒性,造成了严重的污染清除挑战.
- 三酶 (PTE) 是降解V型神经毒剂的关键酶,工程变体显示出更好的疗效.
- 这种10-2-C3(C59V/C227V) PTE突变体对V型药物具有较强的活性.
研究的目的:
- 阐明工程PTE突变体 (10-2-C3) 对合VX神经毒剂的催化机制.
- 调查环7在基质结合,运输和催化过程中的形状变化的作用.
- 了解突变酶增强立体选择性的基础.
主要方法:
- 使用量子力学/分子力学 (QM/MM) 计算来研究反应路径.
- 分子力学分子动力学 (MM MD) 模拟用于分析构造变化和基质相互作用.
- 分析的重点是突变PTE与VX的不同立体异构体的相互作用.
主要成果:
- 循环7中的形状变化显著影响基质结合,运输和催化过程.
- 改造的PTE突变体对VX.的更有毒的Sp立体异构体表现出增强的活性.
- 对于 Sp 立体同位素的降解,观察到 22.4 kcal/mol 的降低能量屏障.
结论:
- 循环7重新配置是导致工程PTE突变的立体选择性的一个关键因素.
- 这项研究为设计和优化PTE变体提供了理论见解,以实现高效的神经毒剂消毒.
- 了解这些机制有助于开发化学战剂的先进酶生物降解策略.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Enhanced Elimination of Poison
587
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
587
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
Drug Metabolism: Phase II Reactions
4.2K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.2K
Fusion of Secretory Vesicles with the Plasma Membrane
11.9K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.9K


